Carvedilol [Coreg].
Kukin
M
M
Cardiovascular Institute, Mt. Sinai Medical Center, New York, New York, USA.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002227:Carbazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000077261:Carvedilol; D018849:Controlled Clinical Trials as Topic; D004311:Double-Blind Method; D017277:Drug Approval; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D011412:Propanolamines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol